Skip to main content

BIIB Competitors

profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptionsprice historyeventsinsiders

Biogen Inc. News

Stock Market Today - 5/3: Stocks End Higher Amid Fed Rate Hike Bets; Treasury Yields Ease

Stocks finish higher Tuesday as the Federal Reserve begins its two-day policy meeting amid bets on faster and deeper near-term rate hikes.

Biogen Stock Gains After Q1 Earnings Miss; CEO Michel Vounatsos Exits

"I will be leaving at a time of promise for Biogen, with noteworthy potential for value creation," said departing CEO Michel Vounatsos.

Should Biogen Investors Be Worried About Its Alzheimer's Drug?

A Medicare policy decision might hurt sales of this biotech giant's Alzheimer's drug.

Biogen's ALS Drug Won't Move Forward After Trial Failures

Biogen will stop developing a drug to treat a severe neurodegenerative disease, as it did not show sufficient benefit when tested in trials.

Novartis and Roche Have Expensive Drugs That Scare Away Competitors

A brief snapshot of some medical breakthroughs that are among the costliest in the world.

Breaking News

FTX Reportedly Close to Buying BlockFi

An acquisition could take several months to close, and the price could shift between now and Friday.

Morningstar's Five Coping Mechanisms for Bear Market

The S&P 500 is in a bear market, having lost 20% so far this year. So what’s an investor to do?

Economist Roubini: Why Stocks Poised for 50% Wipeout

The stock market is off to its worst start to a year since 1962, with the S&P 500 dropping 21% in the first half of 2022.

Who Is the Mystery Crypto Queen on the Run After an Alleged Scam?

The FBI is offering anyone who helps arrest OneCoin co-founder Dr. Ruja Ignatova $100,000.